Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial
-
Published:2002-08
Issue:9332
Volume:360
Page:505-515
-
ISSN:0140-6736
-
Container-title:The Lancet
-
language:en
-
Short-container-title:The Lancet
Cited by
409 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献